Table: begin end state 1 28 cytoplasmic 29 48 transmembrane 49 53 non-cytoplasmic 54 72 transmembrane 73 102 cytoplasmic 103 124 transmembrane 125 142 non-cytoplasmic 143 161 transmembrane 162 171 cytoplasmic 172 191 transmembrane 192 210 non-cytoplasmic 211 234 transmembrane 235 254 cytoplasmic 255 277 transmembrane 278 300 non-cytoplasmic 301 323 transmembrane 324 344 cytoplasmic 345 362 transmembrane 363 366 non-cytoplasmic 367 368 transmembrane 369 369 non-cytoplasmic 370 391 transmembrane 392 403 cytoplasmic 404 424 transmembrane 425 426 non-cytoplasmic
Input: >AO353_21595 MNDQANSVDERYEAAAPASLSSWNRHDTTWMLGLFGTAIGAGTLFLPINAGLGGFWPLLI LALLAFPMTFYAHRGLTRFVLSGRAGADITEVVEEHFGIKAGALITLLYFFAIFPILLIY SVALTNTVGSFLEHQLHIMPPPRAILSFVLILGLLAVVRCGEQMIVKAMSLMVYPFIVAL LFLAVFLIPHWNGGILETASTLPEPSALLHTLWLAIPVMVFSFNHSPIISAFAVDQKRRY GAHAEERSSQILSRAHTLMVVMVLFFVFSCVLTLSPAQLAEAKAQNLSILSYLANHFSNP TIAFAAPLIAFVAISKSFLGHYIGASEGLKGLIVKSGRRPAPKTLDRMTAAFMLVVCWIV ATLNPSILGMIETLGGPVIAAILFLMPMYAIRKVPAMARYRGQASNVFVTLVGLVAISAL IYSLTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server